BridgeBio Oncology Therapeutics, Inc. (BBOT)
NASDAQ: BBOT · Real-Time Price · USD
8.80
+0.01 (0.11%)
At close: Apr 28, 2026, 4:00 PM EDT
8.97
+0.17 (1.93%)
After-hours: Apr 28, 2026, 6:08 PM EDT
BBOT Market Cap
BBOT has a market cap or net worth of $704.29 million as of April 28, 2026. Its market cap has increased by 181.03% in one year.
Market Cap
704.29M
Enterprise Value
283.20M
1-Year Change
181.03%
Ranking
Category
Stock Price
$8.80
Market Cap Chart
Since February 9, 2024, BBOT's market cap has increased from $38.21M to $704.29M, an increase of 1,743.08%. That is a compound annual growth rate of 272.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 703.49M | -29.75% |
| Dec 31, 2025 | 1.00B | 305.70% |
| Dec 31, 2024 | 246.84M | 545.98% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Allogene Therapeutics | 770.51M |
| SpyGlass Pharma | 760.29M |
| Relmada Therapeutics | 748.90M |
| Absci | 732.97M |
| Solid Biosciences | 731.07M |
| Tenax Therapeutics | 716.78M |
| Lexicon Pharmaceuticals | 709.67M |
| Gyre Therapeutics | 703.12M |